Amundi’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.06B | Sell |
10,199,754
-2,108,961
| -17% | -$219M | 0.36% | 55 |
|
|
2025
Q1 | $1.21B | Buy |
12,308,715
+311,034
| +3% | +$30.6M | 0.44% | 44 |
|
|
2024
Q4 | $1.15B | Sell |
11,997,681
-560,172
| -4% | -$53.7M | 0.4% | 49 |
|
|
2024
Q3 | $1.08B | Sell |
12,557,853
-2,874,284
| -19% | -$247M | 0.4% | 52 |
|
|
2024
Q2 | $1.17B | Buy |
15,432,137
+4,347,043
| +39% | +$331M | 0.45% | 45 |
|
|
2024
Q1 | $747M | Sell |
11,085,094
-2,610,488
| -19% | -$176M | 0.32% | 70 |
|
|
2023
Q4 | $811M | Sell |
13,695,582
-1,108,328
| -7% | -$65.6M | 0.37% | 59 |
|
|
2023
Q3 | $733M | Sell |
14,803,910
-1,885,154
| -11% | -$93.4M | 0.36% | 54 |
|
|
2023
Q2 | $894M | Buy |
16,689,064
+2,721,748
| +19% | +$146M | 0.45% | 38 |
|
|
2023
Q1 | $709M | Sell |
13,967,316
-329,530
| -2% | -$16.7M | 0.38% | 50 |
|
|
2022
Q4 | $655M | Sell |
14,296,846
-1,110,502
| -7% | -$50.9M | 0.36% | 61 |
|
|
2022
Q3 | $636M | Buy |
15,407,348
+5,164,607
| +50% | +$213M | 0.38% | 49 |
|
|
2022
Q2 | $376M | Buy |
10,242,741
+852,496
| +9% | +$31.3M | 0.3% | 85 |
|
|
2022
Q1 | $422M | Buy |
9,390,245
+1,812,929
| +24% | +$81.5M | 0.29% | 88 |
|
|
2021
Q4 | $338M | Sell |
7,577,316
-206,963
| -3% | -$9.22M | 0.21% | 119 |
|
|
2021
Q3 | $338M | Buy |
7,784,279
+1,498,957
| +24% | +$65M | 0.24% | 95 |
|
|
2021
Q2 | $269M | Buy |
+6,285,322
| New | +$269M | 0.19% | 131 |
|